๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prospective Study of Indolent Non-follicular Non-Hodgkin's Lymphoma: Validation of Gruppo Italiano Per Lo Studio Dei Linfomi ( GISL ) Prognostic Criteria for Watch and Wait Policy

โœ Scribed by Morabito, Fortunato; Baldini, Luca; Stelitano, Caterina; Luminari, Stefano; Frassoldati, Antonio; Merli, Francesco; Colombi, Mariangela; Sabbatini, Roberto; Brugiatelli, Maura; Federico, Massimo

Book ID
121647750
Publisher
Informa plc
Year
2002
Tongue
English
Weight
201 KB
Volume
43
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Single-dose palonosetron for prevention
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
โœ Nicola Di Renzo; Antonella Montanini; Donato Mannina; Alessandra Dondi; Stefania ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 141 KB
A pilot study on the use of the proMACE-
A pilot study on the use of the proMACE-cytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma
โœ Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 2 views

## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-